Impact of Serum Apolipoprotein A-I on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer: a Propensity Score-Matched Analysis()

PURPOSE: We aimed to investigate the role of apolipoprotein A-I (ApoA-I) as a predictor of prognosis and treatment efficacy of bevacizumab in patients with metastatic colorectal cancer (mCRC) treated with first-line chemotherapy with or without bevacizumab. METHODS: We conducted a retrospective stud...

Full description

Saved in:
Bibliographic Details
Published in:Transl Oncol
Main Authors: Quan, Qi, Huang, Yuanyuan, Chen, Qi, Qiu, Huijuan, Hu, Qiaozhen, Rong, Yuming, Li, Tingwei, Xia, Liangping, Zhang, Bei
Format: Artigo
Language:Inglês
Published: Neoplasia Press 2017
Subjects:
Original article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5334545/
https://ncbi.nlm.nih.gov/pubmed/28292509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2017.01.006
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items